You are using an older browser version. Please use a supported version for the best MSN experience.

The first approved COVID-19 drug is far from 'amazing'

Business Insider logo Business Insider 10/26/2020 lramsey@businessinsider.com (Lydia Ramsey Pflanzer)

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.

Hollis Johnson/Business Insider © Hollis Johnson/Business Insider Hollis Johnson/Business Insider

Hello, 

The coronavirus pandemic is overwhelming the US yet again, with the country recording its 2 worst-ever days of infection over the weekend.

"We are not going to control the pandemic," White House Chief of Staff Mark Meadows said Sunday on CNN.

Also in healthcare news: Gilead's set to make billions on a drug that's far from "amazing", AstraZeneca and Johnson & Johnson have restarted vaccine trials in the US, and universal masking could save 130,000. 

an empty bottle on a table: Vials of the drug Remdesivir pictured during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic. ULRICH PERREY/POOL/AFP via Getty Images © ULRICH PERREY/POOL/AFP via Getty Images Vials of the drug Remdesivir pictured during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic. ULRICH PERREY/POOL/AFP via Getty Images

Gilead is set to sell billions of dollars of a coronavirus drug that's far from 'amazing' after the US approved remdesivir to treat COVID-19

Read the full story from Andrew Dunn here>>

a group of empty glasses on a table: Capped vials are being pictured during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222 VINCENZO PINTO/AFP via Getty Images © Provided by Business Insider Capped vials are being pictured during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222 VINCENZO PINTO/AFP via Getty Images

AstraZeneca and Johnson & Johnson get FDA green light to resume coronavirus vaccine trials in the US after participants got sick

Read the full story from Allana Akhtar here>> 

a man wearing a suit and tie: President Donald Trump. AP Photo/Alex Brandon © AP Photo/Alex Brandon President Donald Trump. AP Photo/Alex Brandon

Universal mask-wearing could save 130,000 US lives before March, mitigating the worst of this 3rd coronavirus surge

Read the full story from Aria Bendix here>>

More stories we're reading:

Subscribe here for daily updates from the healthcare team!

- Lydia 

Read the original article on Business Insider

Video: Stock Gains Continue as Gilead, Moderna Vaccines Progress (TheStreet)

UP NEXT
UP NEXT
AdChoices
AdChoices

More from Business Insider

Business Insider
Business Insider
image beaconimage beaconimage beacon